According to the Zhitong Finance App, Medtech Healthcare (688310.SH) disclosed its 2022 annual performance report. The company achieved total annual revenue of 384 million yuan, an increase of 21.76% over the previous year. Net profit attributable to owners of the parent company was 65.2396 million yuan, an increase of 1.18% over the previous year. Net profit attributable to parent company owners after deducting non-recurring profit and loss was 56.9084 million yuan, a year-on-year decrease of 1.89%. Basic earnings per share were $0.78 per share.

During the reporting period, the increase in the company's net profit was low, mainly due to increases in share payment fees, etc. The company's share payment expenses during the reporting period were 156.554 million yuan. The impact of this fee, including recurring profit and loss, on the return mother's net profit was 136.354 million yuan. As a result, net profit attributable to owners of the parent company after excluding the impact of share payment fees in 2022 was 78.875 million yuan, an increase of 15.99% over the previous year; net profit attributable to owners of the parent company after excluding the impact of share payment fees was 705.4438 million yuan, an increase of 14.65% over the previous year.